501666-24-6 Usage
Uses
Used in Pharmaceutical Industry:
PD 312236 is used as a research compound for the development of new anticonvulsant and anxiolytic medications. Its structural similarity to pregabalin makes it a valuable tool in understanding the mechanisms of action and potential therapeutic applications of GABA analogues.
Used in Neurological Applications:
PD 312236 is used as a potential therapeutic agent for the treatment of neurological disorders, such as epilepsy and neuropathic pain. Its degradation from pregabalin suggests that it may have similar or improved efficacy in managing these conditions, offering a new avenue for research and development in the field of neurology.
Used in Anxiety Treatment:
PD 312236 is used as a potential anxiolytic agent for the treatment of generalized anxiety disorder and other anxiety-related conditions. Its connection to pregabalin, a known anxiolytic, indicates that it may have similar or enhanced effects in alleviating anxiety symptoms, providing a new option for patients and healthcare professionals.
Used in Drug Delivery Systems:
PD 312236 can be used as a component in the development of novel drug delivery systems, particularly for the targeted delivery of anticonvulsant, anxiolytic, and analgesic medications. Its unique structure may allow for improved bioavailability, enhanced efficacy, and reduced side effects when compared to traditional drug formulations.
Check Digit Verification of cas no
The CAS Registry Mumber 501666-24-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,1,6,6 and 6 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 501666-24:
(8*5)+(7*0)+(6*1)+(5*6)+(4*6)+(3*6)+(2*2)+(1*4)=126
126 % 10 = 6
So 501666-24-6 is a valid CAS Registry Number.
501666-24-6Relevant academic research and scientific papers
Pregabalin lactose conjugates
-
, (2008/06/13)
In accordance with the present invention, there is provided pregabalin lactose conjugate compounds. Also provided as part of the present invention is a novel method of central nervous system disorders or diseases including seizure disorders, pain, depression, anxiety, sleep disorders, consumptive disorders, psychosis, tardive dyskinesia, Huntington's disease, or Parkinson's disease in a subject by administering to the subject a pharmaceutically effective amount of a pregabalin lactose conjugate.
